(openPR) - Axium Healthcare Pharmacy, one of the nation’s largest independent specialty pharmacy providers, announced today the addition of VictrelisTM and IncivekTM to its HEPVisionsSM Therapy Management Program.

The announcement comes on the heels of the FDA’s approval of Merck’s VictrelisTM and Vertex’s IncivekTM. Both drugs are approved for use in combination with peg interferon and ribavirin, creating a triple therapy regimen.

Clinical trials have shown that using one of the two new drugs along with peg interferon and ribavirin drugs is more effective at producing a sustained virological response (SVR).

“Axium is pleased to add VictrelisTM and IncivekTM to the HEPVisionsSM program,” said Mark Montgomery, President and CEO of Axium Healthcare Pharmacy. “The new triple therapy regimen is complex and expensive. Careful patient education, monitoring, and adherence are keys to successful treatment.”

Through Axium’s HEPVisionsSM program, Axium’s clinical team provides comprehensive compliance support, patient education, side effect management, clinical interventions and communication with the patientand physician to coordinate the treatment plan. In addition, Axium offers 24-hour Pharmacist/Nurse support, prior authorization assistance, refill management calls, coordination of patient assistance programs, and ongoing delivery coordination.

Marketing Contact: Eireen Luna Bajaria
Phone: 1-888-315-3395
Email: Eireen.Bajaria@axiumhealthcare.com

Eireen Luna Bajaria invites you to learn more about Healthcare and specialty pharmacy, on www.axiumhealthcare.com/, you’ll find all kind of services you may be interested.

About Axium Healthcare Pharmacy

Axium Healthcare Pharmacy, Inc. is one of the nation’s largest independent specialty pharmacy providers licensed and permitted to operate in all 50 states and Puerto Rico. Axium focuses on therapy management programs for patients with serious and chronic conditions. Therapy management programs include: Hepatitis C, Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Hemophilia, Growth Hormone Deficiency plus others. Through Axium’s therapy management program, Axium is able to deliver high-quality, patient-focused care and personalized superior service combined with dedicated clinical expertise which further brings a new level of care for the patients. For more information, contact Axium Healthcare Pharmacy at 888.315.3395 or by email info@axiumhealthcare.com.

Axium Healthcare
550 Technology Park
Lake Mary, FL 32746
Vayumedia
prcontact@vayumedia.com